Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 32.270
- -0.470-1.44%
Close Apr 7 16:00 ET
- 32.820
- +0.550+1.70%
Pre 04:22 ET
1.80BMarket Cap24.45P/E (TTM)
34.260High31.970Low1.21MVolume32.150Open32.740Pre Close39.61MTurnover2.50%Turnover Ratio24.45P/E (Static)55.81MShares40.28052wk High1.74P/B1.56BFloat Cap25.53052wk Low--Dividend TTM48.49MShs Float61.250Historical High--Div YieldTTM7.00%Amplitude4.300Historical Low32.629Avg Price1Lot Size
Supernus Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.94%661.82M | 5.99%174.16M | 14.17%175.69M | 24.17%168.33M | -6.58%143.64M | -8.95%607.52M | -1.80%164.31M | -13.24%153.88M | -20.28%135.56M | 0.82%153.76M |
| Operating revenue | 8.94%661.82M | 5.99%174.16M | 14.17%175.69M | 24.17%168.33M | -6.58%143.64M | -8.95%607.52M | -1.80%164.31M | -13.24%153.88M | -20.28%135.56M | 0.82%153.76M |
| Cost of revenue | -7.01%77.91M | 32.97%26.1M | -10.30%17.58M | -15.05%17.92M | -30.48%16.31M | -3.95%83.78M | -14.49%19.63M | -24.26%19.6M | 3.10%21.09M | 30.83%23.46M |
| Gross profit | 11.49%583.91M | 2.33%148.06M | 17.74%158.11M | 31.39%150.41M | -2.28%127.34M | -9.70%523.74M | 0.22%144.69M | -11.35%134.28M | -23.48%114.47M | -3.17%130.3M |
| Operating expense | -0.39%508.36M | 0.48%126.3M | -6.57%118.28M | 0.71%132.2M | 3.79%131.58M | -4.50%510.34M | 11.79%125.7M | -16.99%126.6M | -4.54%131.27M | -3.92%126.78M |
| Selling and administrative expenses | -4.39%321.58M | -2.30%79.41M | -15.66%69.75M | -1.01%85.9M | 1.07%86.52M | -10.83%336.36M | 9.88%81.28M | -26.37%82.7M | -13.63%86.78M | -5.37%85.6M |
| -Selling and marketing expense | -0.83%227.29M | -1.24%54.59M | -4.33%54.33M | -1.82%58.8M | 4.08%59.57M | --229.19M | --55.28M | -33.74%56.79M | -18.60%59.89M | -5.43%57.23M |
| -General and administrative expense | -12.02%94.29M | -4.57%24.82M | -40.48%15.42M | 0.79%27.1M | -5.00%26.95M | --107.18M | --26.01M | -2.61%25.92M | -0.03%26.89M | -5.27%28.37M |
| Research and development costs | 18.78%108.8M | 22.70%28.65M | 28.17%29.04M | 7.40%26.18M | 17.53%24.93M | 22.86%91.59M | 31.35%23.35M | 15.86%22.66M | 48.79%24.38M | 1.79%21.21M |
| Depreciation amortization depletion | -5.35%77.98M | -13.41%18.24M | -8.26%19.49M | 0.00%20.11M | 0.86%20.14M | -0.30%82.39M | 1.79%21.07M | 2.90%21.24M | -2.60%20.11M | -3.28%19.97M |
| -Depreciation and amortization | -5.35%77.98M | -13.41%18.24M | -8.26%19.49M | 0.00%20.11M | 0.86%20.14M | -0.30%82.39M | 1.79%21.07M | 2.90%21.24M | -2.60%20.11M | -3.28%19.97M |
| Operating profit | 463.72%75.56M | 14.60%21.76M | 418.47%39.83M | 208.44%18.21M | -220.37%-4.25M | -70.62%13.4M | -40.53%18.99M | 840.79%7.68M | -238.94%-16.8M | 34.08%3.53M |
| Net non-operating interest income expense | 101.59%16.2M | 150.60%4.98M | 134.04%4.1M | 711.52%3.73M | -11.59%3.4M | -45.02%8.04M | 146.40%1.99M | 62.28%1.75M | 2,190.91%460K | -69.89%3.84M |
| Non-operating interest income | 55.02%16.2M | 150.60%4.98M | 134.04%4.1M | 172.48%3.73M | -36.48%3.4M | -51.81%10.45M | -17.25%1.99M | -37.53%1.75M | -23.38%1.37M | -63.63%5.35M |
| Non-operating interest expense | --0 | --0 | --0 | --0 | --0 | -65.84%2.42M | --0 | --0 | -49.72%910K | -22.50%1.51M |
| Other net income (expense) | 132.72%6.11M | 98.22%-356K | 122.81%1.02M | 651.27%4.36M | -33.52%1.1M | -3,761.18%-18.67M | -931.32%-19.99M | 193.83%456K | -6.33%-790K | 347.67%1.65M |
| Special income (charges) | 132.72%6.11M | 98.22%-356K | 122.81%1.02M | 651.27%4.36M | -33.52%1.1M | -3,761.18%-18.67M | -931.32%-19.99M | 193.83%456K | -6.33%-790K | 347.67%1.65M |
| -Less：Restructuring and merger&acquisition | -302.77%-6.11M | 274.51%356K | -122.81%-1.02M | -651.27%-4.36M | 33.52%-1.1M | -197.45%-1.52M | 91.51%-204K | -193.83%-456K | 6.33%790K | -347.67%-1.65M |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --20.19M | ---- | ---- | ---- | ---- |
| Income before tax | 3,434.49%97.87M | 2,564.85%26.38M | 354.47%44.94M | 253.57%26.3M | -97.31%243K | -95.44%2.77M | -97.18%990K | 2,327.25%9.89M | -251.25%-17.13M | -38.76%9.02M |
| Income tax | 1,552.10%24.01M | 6,075.14%11.05M | -75.08%6.45M | 139.19%6.39M | 101.50%119K | 4,440.63%1.45M | -101.92%-185K | 1,279.43%25.87M | -571.12%-16.3M | 27.19%-7.93M |
| Net income | 5,512.84%73.87M | 1,204.51%15.33M | 340.97%38.5M | 2,496.63%19.92M | -99.27%124K | -97.83%1.32M | -95.39%1.18M | -1,013.44%-15.98M | -110.57%-831K | -33.84%16.95M |
| Net income continuous Operations | 5,512.84%73.87M | 1,204.51%15.33M | 340.97%38.5M | 2,496.63%19.92M | -99.27%124K | -97.83%1.32M | -95.39%1.18M | -1,013.44%-15.98M | -110.57%-831K | -33.84%16.95M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 5,512.84%73.87M | 1,204.51%15.33M | 340.97%38.5M | 2,496.63%19.92M | -99.27%124K | -97.83%1.32M | -95.39%1.18M | -1,013.44%-15.98M | -110.57%-831K | -33.84%16.95M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 5,512.84%73.87M | 1,204.51%15.33M | 340.97%38.5M | 2,496.63%19.92M | -99.27%124K | -97.83%1.32M | -95.39%1.18M | -1,013.44%-15.98M | -110.57%-831K | -33.84%16.95M |
| Basic earnings per share | 6,600.00%1.34 | 1,507.99%0.28 | 341.38%0.7 | 1,900.00%0.36 | -99.27%0.0023 | -98.23%0.02 | -96.30%0.0174 | -1,066.67%-0.29 | -113.33%-0.02 | -35.42%0.31 |
| Diluted earnings per share | 6,500.00%1.32 | 1,450.57%0.27 | 337.93%0.69 | 1,900.00%0.36 | -99.23%0.0022 | -98.08%0.02 | -95.95%0.0174 | -1,066.67%-0.29 | -114.29%-0.02 | -32.56%0.29 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call